Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Developing "Stronger" Radio Frequency ID Guidance For Drug Tracking

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA Acting Commissioner Crawford says there will be an update on the RFID guidance "about mid-year." The document will "urge in even stronger terms the wide use of this technology." Crawford believes the U.S. is behind EU countries in adopting RFID for tracking drugs.

You may also be interested in...



Cephalon Initiates Radio Frequency Identification Pilot

The pilot will lay a foundation "to support future e-pedigree initiatives driven by regulatory agencies," Cephalon says.

Cephalon Initiates Radio Frequency Identification Pilot

The pilot will lay a foundation "to support future e-pedigree initiatives driven by regulatory agencies," Cephalon says.

FDA Planning Enforcement Response To DTC Ads Aired Last Weekend

Acting Commissioner Crawford has formed an "informal" task force to "see if there is a violation we can pursue." Erectile dysfunction ads are a particular sore point, Crawford indicates. Action could come before the end of the week.

Related Content

Topics

UsernamePublicRestriction

Register

PS061817

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel